Lyophilized pulmonary surfactant peptide compositions
US5952303A · kind A · utility
17Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 1997 |
| Grant date | Sep 14, 1999 |
| Priority date | — |
| Expiry date | Mar 29, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1709
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved solid pharmaceutical composition comprising a lyophilized liposomal KL4 pulmonary surfactant composition comprising: PA1 (a) about 1 to about 10 percent weight KL4 polypeptide; and PA1 (b) 50 to about 100 weight percent phospholipid comprised of about 3 parts DPPC to about 1 part POPG. A facile process for the production of the lyophilized solid composition is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.